Latest Articles
Aussie tradie and endometriosis campaigner Brett Hinton reveals why we need to 'smash the stigma' - Nine - Honey
Aussie tradie and endometriosis campaigner Brett Hinton reveals why we need to 'smash the stigma' Nine - Honey
Published: June 3, 2025, 6:47 a.m.
From period pain to heart disease, the gender health gap is real — here’s how to close it - Down To Earth
From period pain to heart disease, the gender health gap is real — here’s how to close it Down To Earth
Published: June 3, 2025, 6:12 a.m.
CNN Faces Changes as Veteran Correspondent Departs - Men's Journal
CNN Faces Changes as Veteran Correspondent Departs Men's Journal
Published: June 3, 2025, 1:22 a.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Haley Pullos’ Latest Post Has Fans Begging For Her General Hospital Return - Soap Hub
Haley Pullos’ Latest Post Has Fans Begging For Her General Hospital Return Soap Hub
Published: June 2, 2025, 7:49 p.m.
OPINION - I’ve passed out, been hospitalised and still done my job — Bella Hadid is right, working on your period should be illegal - MSN
OPINION - I’ve passed out, been hospitalised and still done my job — Bella Hadid is right, working on your period should be illegal MSN
Published: June 2, 2025, 6:50 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance
Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo
Published: June 2, 2025, 6:30 p.m.
Bunnie Xo Considers Stopping IVF as She Endures Worst Side Effects Yet - k99.com
Bunnie Xo Considers Stopping IVF as She Endures Worst Side Effects Yet k99.com
Published: June 2, 2025, 4:30 p.m.
Link copied to clipboard!